Christian Elze

Insider Reports History

Location
Carmiel
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christian Elze:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protalix BioTherapeutics, Inc. Director Common Stock 7.5K $11.6K $1.55 Sep 3, 2025 By Trust
Protalix BioTherapeutics, Inc. Director Stock Options (Right to Buy) 15K Sep 3, 2025 Direct

Insider Reports Filed by Christian Elze

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLX Protalix BioTherapeutics, Inc. Sep 3, 2025 2 $0 4 Sep 4, 2025 Director
PLX Protalix BioTherapeutics, Inc. Jun 26, 2025 0 $0 3 Jul 3, 2025 Director